PASITHEA THERAPEUTICS CORP C/WTS 12/08/2026 (TO PUR COM)(KTTAW.US)

Last Updated 19:00:00 ET
longbridge loading

Pasithea Therapeutics Appoints Kartik Krishnan As CMO

rttnews·
US
KTTAW
0.00%
US
KTTA
-8.75%
US
IXJ
+0.79%
rttnews·
US
KTTAW
0.00%
US
KTTA
-8.75%
US
IXJ
+0.79%

Pasithea Therapeutics Announces Appointment of Kartik Krishnan, M.D., Ph.D. as Chief Medical Officer | KTTA Stock News

StockTitan·
US
KTTAW
0.00%
US
KTTA
-8.75%
US
LABU
-2.35%
StockTitan·
US
KTTAW
0.00%
US
KTTA
-8.75%
US
LABU
-2.35%

Pasithea Therapeutics Announces Grant of Rare Pediatric Disease Designation (RPDD) by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1) | KTTA Stock News

StockTitan·
US
KTTAW
0.00%
US
KTTA
-8.75%
US
FBT
+0.54%
StockTitan·
US
KTTAW
0.00%
US
KTTA
-8.75%
US
FBT
+0.54%

PASITHEA THERAPEUTICS CORP C/WTS 12/08/2026 (TO PUR COM) | 10-K: FY2025 Revenue: USD 0

Earnings Watch·
US
KTTAW
0.00%
Earnings Watch·
US
KTTAW
0.00%

MindBio to Raise Up to $650,000 for AI Intoxication Detection Expansion in Mining Sector

Tip Ranks·
US
KTTAW
0.00%
US
KTTA
-8.75%
US
PBE
+0.11%
Tip Ranks·
US
KTTAW
0.00%
US
KTTA
-8.75%
US
PBE
+0.11%

MindBio Advances Large-Scale Deployment of Voice Intoxication Detection Through Integrated Edge AI Hardware-Software Platform

The newswire.ca·
US
BTAI
-4.42%
US
BIB
+0.05%
US
SBIO
-1.24%
The newswire.ca·
US
BTAI
-4.42%
US
BIB
+0.05%
US
SBIO
-1.24%
© 2026 Longbridge｜Disclaimer